基本信息
views: 1
Career Trajectory
Bio
Areas of expertise include diabetes, cardiovascular and nervous system diseases, intensive care, anesthesiology and physical therapy. He is a globally recognized expert in adaptive design, because he was one of the first to design and analyze the phase II/III trial of pediatric dermatology (Hemangiol) that was accepted by regulatory agencies and published in NEJM. This research has become the benchmark of confirmatory adaptive design.
Other statistical research interests include survival analysis, cluster randomized trials and robust biostatistics. He is an active member of ACTA clinical trial innovation reference group. Heritier is the principal investigator of several trials funded by NHMRC
Research area keywords
BiostatisticsClinical trial methodologyAdaptive designsCluster randomised trialsRobust statisticsSurvival analysisSemi-Markov processesStepped-wedge designsJoint modellingcluster cross-over trials
Research Interests
Papers共 159 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Timothy Makar, Margaret Hezkial, Mayank Vasudeva,Dominic Walpole, John Xie, Chris Zi-Fan Zhao,Bobby Ou Yang, Saranya Ramesh, Tom Larsen,Stephane Heritier,Toby Richards,Lachlan F Miles
Anaesthesiano. 8 (2024): 839-848
arxiv(2024)
Cited0Views0Bibtex
0
0
BMJ Openno. 1 (2024): e076246-e076246
Osteoarthritis and Cartilage (2024): S494
Osteoarthritis and Cartilage Openpp.100486, (2024)
Mahnuma M Estee,YuanYuan Wang,Stephane Heritier,Donna M Urquhart,Flavia M Cicuttini, Mark A Kotowicz,Kara B Anderson, Sharon L Brennan-Olsen, Julie A Pasco,Anita E Wluka
JBMR plusno. 8 (2024): ziae076-ziae076
BMJ OPENno. 12 (2023): e079489-e079489
Research Square (Research Square) (2023)
Load More
Author Statistics
#Papers: 159
#Citation: 11868
H-Index: 33
G-Index: 108
Sociability: 8
Diversity: 3
Activity: 46
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn